Principia Biopharma Inc. (PRNB) has 38 open-market insider trades by 16 insiders since 2018. The most active filer is Martin Babler, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| OrbiMed Capital GP IV LLC | 10% Owner | — | 1 | $30.3M | 2019-05-21 |
| Daniel J. Becker | Dir | — | 4 | $26.4M | 2020-09-28 |
| Simeon George | Dir | — | 2 | $14.6M | 2020-09-28 |
| Glaxosmithkline PLC | — | — | 2 | $14.6M | 2019-10-18 |
| New Leaf Ventures II, L.P. | 10% Owner | — | 1 | $10.5M | 2019-08-13 |
| Martin Babler | CEOPres | — | 5 | $5.0M | 2020-09-28 |
| Anand Mehra | 10% Owner | — | 1 | $4.6M | 2018-09-18 |
| Orbimed Advisors LLC | 10% Owner | — | 1 | $4.3M | 2018-09-18 |
| Srinivas Akkaraju | Dir | — | 1 | $3.0M | 2018-09-18 |
| Dolca Thomas | — | — | 3 | $2.7M | 2020-09-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Roy C. Hardiman | — | Sell | $500K | 2020-09-18 |
| Christopher Y. Chai | CFO | Sell | $745K | 2020-08-18 |
| Dolca Thomas | — | Sell | $1.5M | 2020-08-18 |
| David M. Goldstein | CSO | Sell | $993K | 2020-08-10 |
| Dolca Thomas | — | Sell | $1.2M | 2020-07-15 |
| Alan Colowick | Director | Sell | $450K | 2020-07-01 |
Companies that share insiders with PRNB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Martin Babler | CEO & President | Sell | $1.8M | 2020-06-23 |
| Stefani Wolff | — | Sell | $639K | 2020-06-15 |
| Roy C. Hardiman | — | Sell | $612K | 2020-06-12 |
| Christopher Y. Chai | CFO | Sell | $977K | 2020-05-19 |
| David M. Goldstein | CSO | Sell | $722K | 2020-05-07 |
| Alan Colowick | Director | Sell | $501K | 2020-05-01 |
| Stefani Wolff | — | Sell | $334K | 2020-03-16 |
| Roy C. Hardiman | — | Sell | $481K | 2020-03-13 |
| Martin Babler | CEO & President | Sell | $1.9M | 2020-03-03 |